Table 2 Baseline investigation and laboratory work up on admission
No = 96 | |
|---|---|
CT CHEST | |
CORAD 3 | 12 (12.5%) |
CORAD 4 | 20 (20.8%) |
CORAD 5 | 64 (66.7%) |
CT pulmonary angiogram proven pulmonary embolism | |
No | 86 (89.6%) |
Yes | 10 (10.4%) |
TLC /cmm | |
Mean ± SD | 16.90 ± 3.76 |
Range | 11–30 |
Serum ferritin | |
High | 96 (100.0%) |
CRP mg/l | |
Median(IQR) | 25 (20.5–32.5) |
Range | 10–110 |
ESR mm 1st h | |
Median(IQR) | 32 (23–43.5) |
Range | 10–102 |
RV Base dimensions mm | |
Mean ± SD | 36.44 ± 3.18 |
Range | 32–48 |
RA | |
Normal | 88 (91.7%) |
Dilated | 8 (8.3%) |
TAPSE mm | |
Mean ± SD | 19.71 ± 2.35 |
Range | 14–28 |
TR JET | |
Moderate | 59 (61.5%) |
Mild | 30 (31.2%) |
Severe | 7 (7.3%) |
RVSP (mmHg) | |
Mean ± SD | 36.34 ± 8.62 |
Range | 20–65 |
RVSP groups | |
Normal RVSP | 26 (27.1%) |
High RVSP (≥ 35mmhg) | 70 (72.9%) |
PREVIOUS COVID INEFCTION | |
No | 92 (95.8%) |
Yes | 4 (4.2%) |
Mortality | |
No | 93 (96.9%) |
Yes | 3 (3.1%) |
Troponin and CK | |
Positive | 82 (85.4%) |
Negative | 14 (14.6%) |
LV systolic function | |
Normal (EF ≥ 50%) | 85 (88.5%) |
Impaired | 11 (11.5%) |